P 3 Therapeutics

Zagreb, Croatia · Founded 2024 · Privately Held (backing)

Developer of novel anti-inflammatory drugs designed to address unmet needs in treating Spondyloarthritis. P 3 Therapeutics is based in Zagreb, Croatia and was founded in 2024. Its last reported valuation was $5.4 million in Apr 2025. It has raised $110,000.

Last reported valuation
$5.4M
Oct 2026
Priced at
—
Total raised
$110K
Last round
—
No prints on record

No secondary trades in P 3 Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of P 3 Therapeutics with a free account
  • ·Watch P 3 Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where P 3 Therapeutics prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of P 3 Therapeutics stock.